SOPHiA GENETICS SA Stock (NASDAQ:SOPH)
Previous Close
$2.81
52W Range
$2.60 - $6.28
50D Avg
$3.38
200D Avg
$3.62
Market Cap
$187.80M
Avg Vol (3M)
$78.29K
Beta
1.02
Div Yield
-
SOPH Company Profile
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPH Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Asia Pacific | $4.05M | $3.70M | $2.95M |
| Europe, The Middle East And Africa | $46.93M | $43.96M | $34.88M |
| FRANCE | $10.33M | $10.08M | - |
| ITALY | $9.98M | $8.55M | - |
| Latin America | $2.89M | $3.99M | $3.00M |
| North America | $11.30M | $10.73M | $6.73M |
| SPAIN | $5.79M | $6.51M | - |
| SWITZERLAND | $1.49M | $1.43M | - |
| UNITED STATES | $9.32M | $9.46M | - |
Latest
Fiscal year ends in Dec 23 | Currency in USD